Business
Press Release May 12 2022
Sun Pharma Announces US FDA Approval for Generic Mesalamine Extended Release Capsules.
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharma Announces US FDA Approval for Generic Mesalamine Extended Release Capsules. View Attachment","length":282,"tagName":"div"}]